StaphOff Biotech, Inc.

HOPKINTON, MA · Founded 2011 · CIK 0001560051 · Biotech · Private

Therapeutics to prevent or treat antibiotic-resistant Staphylococcal infections

staphoff.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$25K
1 Form D · Oct 2012
168 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$25,000
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2770OCEANYX PHARMACEUTICALS, INC.——
2771Niche Biopharmaceuticals LLC—$525K
2772LACERTA THERAPEUTICS, INC.—$500K
2773StaphOff Biotech, Inc.—$25K
2774Arsenal Biosciences—$579M
2775Invivyd, Inc.—$489M
2776Recursion Pharmaceuticals, LLC—$466M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 1 related persons
  • Naomi BalabanDirector

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.